GARY MCCALL: Open Payments
NPI 1174708283 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 25 payments from 14 companies in 2025. Trend: 2023 $191 · 2024 $410 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Getinge USA Sales, LLC | 1 | $95 |
| Amgen Inc. | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Abbott Laboratories | 2 | $40 |
| ABIOMED | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $30 |
Products named: VASOVIEW HEMOPRO 2, REPATHA, Kerendia, JARDIANCE, VERQUVO, ONPATTRO, KONECT RESILIA, Barostim Neo System.
Industry payments across NY — which companies pay providers there.
